Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Roskilde – page 71

1 178 clinical trials in Roskilde, Denmark across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Roskilde at a glance
1 178
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

1 178 trials in Roskilde

Open in trial search

Fabry's disease

Not recruiting

Study on the Long-Term Safety and Effectiveness of Pegunigalsidase Alfa for Adults with Fabry Disease

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Pegunigalsidase Alfa
  • Sponsor:Chiesi Farmaceutici S.p.A.

Breast cancer

Not recruiting

Study on Atorvastatin for Patients with Early Breast Cancer

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Region Midtjylland

Malignant melanoma

Not recruiting

Study Comparing Naporafenib and Trametinib Combination to Other Therapies for Patients with Previously Treated Unresectable or Metastatic NRAS Mutant Melanoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dacarbazine
  • Sponsor:Erasca Inc.

Study of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Bicycletx Limited

Study of iptacopan effectiveness in achieving remission in patients with active ANCA-associated vasculitis

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Iptacopan
  • Sponsor:Novartis Pharma AG

Study on Long-Term Safety of INBRX-101 for Adults with Alpha-1 Antitrypsin Deficiency Emphysema

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Sanofi AATD Inc.

Cardiac amyloidosis

Not recruiting

Study on the Effectiveness and Safety of Eplontersen for Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Eplontersen
  • Sponsor:Ionis Pharmaceuticals Inc.

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Investigational
Countries:DenmarkDenmark
  • Participants:65+ years
  • Substances:Nerandomilast
  • Sponsor:Boehringer Ingelheim Espana S.A.

Osteochondrodysplasia

Not recruiting

Study on the Effectiveness and Safety of Navepegritide for Adolescents with Achondroplasia

Investigational
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Navepegritide
  • Sponsor:Ascendis Pharma Growth Disorders A/S

Infection

Not recruiting

Title: Study of gentamicin, vancomycin and cefazolin antibiotics to prevent infections in women having breast reconstruction surgery with implants

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Cefazolin Sodium
  • Sponsor:Region Hovedstaden

Cardiac failure chronic+1

Not recruiting

Study on the Effects of Vericiguat in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF) Using the CardioMEMS HF System

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Region Hovedstaden

Type IIa hyperlipidaemia+1

Not recruiting

Study of Bempedoic Acid for Children Aged 6-17 with Familial Hypercholesterolemia

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Bempedoic Acid
  • Sponsor:Esperion Therapeutics Inc.

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Roskilde

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on endometrial carcinoma, non-small cell lung cancer, and chronic myeloid leukemia treatments. Studies evaluate novel therapeutic combinations and targeted approaches for better patient outcomes.

  • Advanced cancer therapies
  • Immunotherapy combinations
  • Molecular response studies

Ongoing investigations into personalized treatment approaches for various cancer types.

02 Cardiovascular Studies

Research focusing on heart failure prevention and cardiovascular disease management. Studies evaluate new treatments and combinations like baxdrostat with dapagliflozin.

  • Prevention strategies
  • Risk reduction therapies
  • Innovative drug combinations

Comprehensive trials aimed at improving cardiovascular outcomes in high-risk populations.

03 Immunology and Dermatology

Clinical investigations into atopic dermatitis, plaque psoriasis, and hidradenitis suppurativa. Evaluating new therapeutic options for chronic inflammatory conditions.

  • Inflammatory skin conditions
  • Novel biological therapies
  • Treatment efficacy studies

Advancing treatment options for patients with moderate to severe skin conditions.

04 Infectious Disease Research

Studies focusing on meningococcal immunization and viral infections. Investigating vaccine safety and efficacy in different age groups, from infants to adults.

  • Vaccine development
  • Immunogenicity studies
  • Prevention strategies

Important research advancing preventive medicine and infection control.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.